Alumis Inc. Common Stock

NASDAQ:ALMS

Biotechnology

Healthcare
$4.40 +0.91%

+$0.21 today

Market cap
$568.87M
Beta
-0.54
P/E (TTM)
-12.2
EPS (TTM)
-$1.90
52W Low $2.76High $30.60

Volume 2.01M

Average 1.31M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$369.52M

FY 2025 · Annual

Investing Cash Flow

$287.88M

FY 2025 · Annual

Financing Cash Flow

$2.07M

FY 2025 · Annual

-99.6% YoY

Cash Flow Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(111.93M)(154.99M)(294.23M)(243.33M)
Depreciation & Amortization250K1.28M3.15M3.5M
Deferred Income Tax000(8.56M)
Stock-Based Compensation5.96M8.63M19.46M43.52M
Change in Working Capital(1.92M)12.06M14.76M26.32M
Accounts Receivables0000
Inventory0000
Accounts Payables1.29M(642K)8.51M(6.04M)
Other Working Capital(3.21M)12.7M6.25M32.35M
Other Non-Cash Items(86K)3.05M1.79M(190.98M)
Operating Cash Flow(107.72M)(129.98M)(255.08M)(369.52M)
Capital Expenditures(2.41M)(4.5M)(1.73M)(653K)
Acquisitions (Net)0000
Purchases of Investments(209.08M)(11.28M)(240.06M)(209.17M)
Sales of Investments142.73M76.25M128M447.96M
Other Investing Activities00049.74M
Investing Cash Flow(68.75M)60.47M(113.79M)287.88M
Debt Repayment0000
Common Stock Issued00193.32M2.08M
Common Stock Repurchased000(17K)
Dividends Paid0000
Other Financing Activities1.73M(96K)40.59M0
Financing Cash Flow101.63M89.68M492.37M2.07M
Effect of Forex Changes0000
Net Change in Cash(74.85M)20.18M123.5M(79.58M)
Free Cash Flow(110.13M)(134.47M)(256.81M)(370.18M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$243.3M
+ D&A$3.5M
+ Stock-Based Comp$43.5M
- Deferred Tax-$8.6M
+ Working Capital$26.3M
- Other Non-Cash-$191.0M
= Operating Cash Flow-$369.5M
- Capex-$653.0K
= Free Cash Flow-$370.2M

Analysis

FY2025 free cash flow is -$370.2M. FCF conversion is 152.1% of net income. Operating cash flow was -$369.5M, with capex of -$653.0K. The largest bridge item is Other Non-Cash at -$191.0M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
4Statement of changes in beneficial ownershipNov 4, 2026
4Statement of changes in beneficial ownershipNov 4, 2026

Does ALMS generate free cash flow?

Alumis Inc. Common Stock (ALMS) generated -$370.18M of free cash flow in fiscal 2025.

How much operating cash flow does ALMS produce?

Operating cash flow was -$369.52M, before capital expenditures of $653,000.00.